Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fortress Biotech, Inc. stock logo
FBIO
Fortress Biotech
$1.75
$1.93
$1.24
$12.00
$33.67M1.52403,078 shs151,035 shs
Kindred Biosciences, Inc. stock logo
KIN
Kindred Biosciences
$9.25
$9.22
$3.46
$9.28
$420.52M1.3840,890 shs178,496 shs
LifeVantage Co. stock logo
LFVN
LifeVantage
$6.05
-9.7%
$6.60
$3.04
$8.69
$77.86M0.7835,078 shs42,786 shs
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
$19.41
+0.6%
$18.88
$10.06
$21.72
$365.30M0.8251,094 shs46,940 shs
Osmotica Pharmaceuticals plc stock logo
OSMT
Osmotica Pharmaceuticals
$1.16
$0.98
$4.95
$69.47M2.34396,682 shs296,500 shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fortress Biotech, Inc. stock logo
FBIO
Fortress Biotech
0.00%-3.85%-9.56%-12.50%-83.61%
Kindred Biosciences, Inc. stock logo
KIN
Kindred Biosciences
0.00%0.00%0.00%0.00%0.00%
LifeVantage Co. stock logo
LFVN
LifeVantage
-9.70%+5.22%-12.32%+7.65%+78.47%
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
+0.62%+4.69%-1.67%+10.47%+78.40%
Osmotica Pharmaceuticals plc stock logo
OSMT
Osmotica Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Fortress Biotech, Inc. stock logo
FBIO
Fortress Biotech
1.3571 of 5 stars
3.51.00.00.00.03.30.6
Kindred Biosciences, Inc. stock logo
KIN
Kindred Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
LifeVantage Co. stock logo
LFVN
LifeVantage
1.8899 of 5 stars
0.05.01.72.70.61.71.3
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
1.704 of 5 stars
2.55.00.00.00.51.71.3
Osmotica Pharmaceuticals plc stock logo
OSMT
Osmotica Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fortress Biotech, Inc. stock logo
FBIO
Fortress Biotech
3.00
Buy$30.001,614.29% Upside
Kindred Biosciences, Inc. stock logo
KIN
Kindred Biosciences
N/AN/AN/AN/A
LifeVantage Co. stock logo
LFVN
LifeVantage
N/AN/AN/AN/A
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
3.00
Buy$24.0023.65% Upside
Osmotica Pharmaceuticals plc stock logo
OSMT
Osmotica Pharmaceuticals
N/AN/AN/AN/A

Current Analyst Ratings

Latest FBIO, LFVN, NATR, KIN, and OSMT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/19/2024
Fortress Biotech, Inc. stock logo
FBIO
Fortress Biotech
Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$5.00
3/15/2024
Fortress Biotech, Inc. stock logo
FBIO
Fortress Biotech
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$10.00
3/13/2024
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$21.50 ➝ $24.00
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fortress Biotech, Inc. stock logo
FBIO
Fortress Biotech
$84.51M0.40N/AN/A$0.10 per share17.50
Kindred Biosciences, Inc. stock logo
KIN
Kindred Biosciences
$42.16M9.97N/AN/A$1.75 per share5.29
LifeVantage Co. stock logo
LFVN
LifeVantage
$213.40M0.36$0.47 per share12.92$2.71 per share2.23
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
$445.32M0.82$1.61 per share12.09$8.36 per share2.32
Osmotica Pharmaceuticals plc stock logo
OSMT
Osmotica Pharmaceuticals
$177.88M0.00N/A1.00$1.50 per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fortress Biotech, Inc. stock logo
FBIO
Fortress Biotech
-$60.64M-$8.22N/AN/AN/A-74.12%-770.86%-32.87%5/20/2024 (Estimated)
Kindred Biosciences, Inc. stock logo
KIN
Kindred Biosciences
-$21.80M-$0.55N/AN/AN/A-529.26%-54.19%-39.76%N/A
LifeVantage Co. stock logo
LFVN
LifeVantage
$2.54M$0.2326.30N/A1.40%19.96%9.48%5/2/2024 (Confirmed)
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
$15.08M$0.7725.21N/A3.39%12.25%7.75%5/14/2024 (Estimated)
Osmotica Pharmaceuticals plc stock logo
OSMT
Osmotica Pharmaceuticals
-$79.59M-$1.59N/AN/AN/A-138.76%-81.23%-20.97%N/A

Latest FBIO, LFVN, NATR, KIN, and OSMT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
LifeVantage Co. stock logo
LFVN
LifeVantage
N/AN/AN/AN/AN/AN/A  
3/28/2024Q4 2023
Fortress Biotech, Inc. stock logo
FBIO
Fortress Biotech
N/A-$0.53-$0.53-$0.53$14.46 million$19.95 million
3/12/2024Q4 2023
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
N/A$0.45+$0.45$0.44N/A$108.94 million
1/30/2024Q2 2024
LifeVantage Co. stock logo
LFVN
LifeVantage
N/A$0.10+$0.10$0.25N/A$51.62 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Fortress Biotech, Inc. stock logo
FBIO
Fortress Biotech
N/AN/AN/AN/AN/A
Kindred Biosciences, Inc. stock logo
KIN
Kindred Biosciences
N/AN/AN/AN/AN/A
LifeVantage Co. stock logo
LFVN
LifeVantage
$0.142.31%N/A60.87%1 Years
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
N/AN/AN/AN/AN/A
Osmotica Pharmaceuticals plc stock logo
OSMT
Osmotica Pharmaceuticals
N/AN/AN/AN/AN/A

Latest FBIO, LFVN, NATR, KIN, and OSMT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/25/2024
LifeVantage Co. stock logo
LFVN
LifeVantage
Quarterly$0.03502.64%2/29/20243/1/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fortress Biotech, Inc. stock logo
FBIO
Fortress Biotech
38.42
1.38
1.26
Kindred Biosciences, Inc. stock logo
KIN
Kindred Biosciences
0.19
7.02
7.02
LifeVantage Co. stock logo
LFVN
LifeVantage
N/A
1.68
1.03
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
N/A
2.16
1.29
Osmotica Pharmaceuticals plc stock logo
OSMT
Osmotica Pharmaceuticals
N/A
0.43
0.42

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Fortress Biotech, Inc. stock logo
FBIO
Fortress Biotech
18719.24 million12.81 millionOptionable
Kindred Biosciences, Inc. stock logo
KIN
Kindred Biosciences
6345.46 millionN/AOptionable
LifeVantage Co. stock logo
LFVN
LifeVantage
24812.87 million12.00 millionOptionable
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
81418.82 million17.90 millionOptionable
Osmotica Pharmaceuticals plc stock logo
OSMT
Osmotica Pharmaceuticals
30262.59 million59.32 millionNot Optionable

FBIO, LFVN, NATR, KIN, and OSMT Headlines

SourceHeadline
Vanda Pharmaceuticals Inc.Vanda Pharmaceuticals Inc.
wsj.com - March 6 at 4:32 PM
RVL Pharmaceuticals PLC (RVLPQ)RVL Pharmaceuticals PLC (RVLPQ)
investing.com - December 19 at 9:08 AM
Other OTC Pharmaceuticals - SeychellesOther OTC Pharmaceuticals - Seychelles
statista.com - October 8 at 8:51 PM
Osmotica Pharmaceuticals is about to announce its earnings — heres what to expectOsmotica Pharmaceuticals is about to announce its earnings — here's what to expect
markets.businessinsider.com - August 14 at 1:21 AM
What Wall Street expects from Osmotica Pharmaceuticalss earningsWhat Wall Street expects from Osmotica Pharmaceuticals's earnings
markets.businessinsider.com - March 19 at 12:43 PM
GRO Biosciences Appoints Rakhshita Dhar to its Board of DirectorsGRO Biosciences Appoints Rakhshita Dhar to its Board of Directors
nz.finance.yahoo.com - January 19 at 9:21 PM
UPDATE – Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales GuidanceUPDATE – Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance
finance.yahoo.com - January 19 at 3:55 PM
Osmotica Pharmaceuticals Announces Corporate Name Change to RVL Pharmaceuticals plc With New Ticker Symbol RVLPOsmotica Pharmaceuticals Announces Corporate Name Change to RVL Pharmaceuticals plc With New Ticker Symbol 'RVLP'
benzinga.com - January 19 at 10:54 AM
Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales GuidanceOsmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance
finance.yahoo.com - January 19 at 10:54 AM
RVL Pharmaceuticals to Host UPNEEQ® Overview and Business Update Webcast on January 19, 2022RVL Pharmaceuticals to Host UPNEEQ® Overview and Business Update Webcast on January 19, 2022
finance.yahoo.com - January 18 at 7:56 AM
Fresh Insights On Osmotica Pharmaceuticals plc (OSMT)Fresh Insights On Osmotica Pharmaceuticals plc (OSMT)
stocksregister.com - January 15 at 6:25 PM
Osmotica Pharmaceuticals plc (OSMT): What Is Good About Stock?Osmotica Pharmaceuticals plc (OSMT): What Is Good About Stock?
marketingsentinel.com - January 11 at 7:36 AM
Osmotica Pharmaceuticals plc to Host UPNEEQ® Overview and Business Update Call on January 19, 2022Osmotica Pharmaceuticals plc to Host UPNEEQ® Overview and Business Update Call on January 19, 2022
finance.yahoo.com - January 6 at 9:24 AM
Boom Or Bust: What Are Osmotica Pharmaceuticals plc’s (NASDAQ:OSMT) Future Prospects?Boom Or Bust: What Are Osmotica Pharmaceuticals plc’s (NASDAQ:OSMT) Future Prospects?
marketingsentinel.com - January 1 at 10:28 AM
Osmotica Pharmaceuticals plc (NASDAQ: OSMT) Shares Rose Recently. However, Trouble May Still Be Lurking.Osmotica Pharmaceuticals plc (NASDAQ: OSMT) Shares Rose Recently. However, Trouble May Still Be Lurking.
stocksregister.com - December 27 at 12:57 PM
Osmotica Pharmaceuticals plc (NASDAQ: OSMT): Why Investors Shouldn’t Ditch OSMT Stock In 2021Osmotica Pharmaceuticals plc (NASDAQ: OSMT): Why Investors Shouldn’t Ditch OSMT Stock In 2021
marketingsentinel.com - December 27 at 12:57 PM
Osmotica Pharmaceuticals plc (NASDAQ:OSMT) Shares Plunged 0.00% In A Week – But Will They Keep Going Up?Osmotica Pharmaceuticals plc (NASDAQ:OSMT) Shares Plunged 0.00% In A Week – But Will They Keep Going Up?
marketingsentinel.com - December 23 at 2:40 PM
James Schaub Is The Executive VP & COO of Osmotica Pharmaceuticals plc (NASDAQ:OSMT) And They Just Picked Up 30% More SharesJames Schaub Is The Executive VP & COO of Osmotica Pharmaceuticals plc (NASDAQ:OSMT) And They Just Picked Up 30% More Shares
nasdaq.com - December 22 at 2:02 PM
Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect ConferenceOsmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect Conference
finance.yahoo.com - December 20 at 6:40 PM
Osmotica Pharmaceuticals plc (NASDAQ: OSMT):The Stock Was Down -2.04 Percent From Its Lows On Friday, So What’s To Come?Osmotica Pharmaceuticals plc (NASDAQ: OSMT):The Stock Was Down -2.04 Percent From Its Lows On Friday, So What’s To Come?
marketingsentinel.com - December 18 at 6:32 PM
Osmotica Pharmaceuticals EPS Diluted (5 Year Growth)Osmotica Pharmaceuticals EPS Diluted (5 Year Growth)
ycharts.com - December 18 at 12:57 AM
Osmotica Pharmaceuticals plc (OSMT) Could Be Sitting On A GoldmineOsmotica Pharmaceuticals plc (OSMT) Could Be Sitting On A Goldmine
stocksregister.com - December 4 at 10:20 AM
What Analysts Were Expecting After Osmotica Pharmaceuticals plc (NASDAQ: OSMT) rose 2.76%What Analysts Were Expecting After Osmotica Pharmaceuticals plc (NASDAQ: OSMT) rose 2.76%
stocksregister.com - November 25 at 2:06 PM
The Future Of Osmotica Pharmaceuticals plc (NASDAQ: OSMT) In 2021The Future Of Osmotica Pharmaceuticals plc (NASDAQ: OSMT) In 2021
stocksregister.com - November 18 at 9:51 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Fortress Biotech logo

Fortress Biotech

NASDAQ:FBIO
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino an oral minocycline drug for the treatment of moderate to severe acne; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Exelderm cream for antifungal intended for topical use; Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Amzeeq; Zilxi; and Accutane capsules for severe recalcitrant nodular acne. It also develops late stage product candidates, such as intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for the treatment of Menkes disease; MB-107 and MB-207 for the treatment of X-linked severe combined immunodeficiency; Cosibelimab for metastatic cancers; CK-101 for the treatment of patients with EGFR mutation-positive NSCLC; CAEL-101 for the treatment of amyloid light chain amyloidosis; Triplex vaccine for cytomegalovirus; and CEVA101 for the treatment of severe traumatic brain injury in adults and children. The company's early stage product candidates include MB-102 for blastic plasmacytoid dendritic cell neoplasm; MB-101 for glioblastoma; MB-104 for multiple myeloma and light chain amyloidosis; MB-106 for B-cell non-hodgkin lymphoma; MB-103 for GBM & metastatic breast cancer to brain; MB-108; MB-105 for prostate and pancreatic cancers; and BAER-101. Its preclinical product candidates comprise AAV-ATP7A gene therapy; AVTS-001 gene therapy; CK-103 BET inhibitor; CEVA-D and CEVA-102; CK-302, an anti-GITR; CK-303, an anti-CAIX; and ONCOlogues, and oligonucleotide platform. It has collaboration arrangements with universities, research institutes, and pharmaceutical companies. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Islands, Florida.
Kindred Biosciences logo

Kindred Biosciences

NASDAQ:KIN
Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.
LifeVantage logo

LifeVantage

NASDAQ:LFVN
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.
Nature

Nature's Sunshine Products

NASDAQ:NATR
Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.
Osmotica Pharmaceuticals logo

Osmotica Pharmaceuticals

NASDAQ:OSMT
Osmotica Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. Its products include Upneeq, M-72, Arbaclofen ER, OS870, Divigel, OB Complete, Methylphenidate ER, Venlafaxine ER tablets (VERT), Hydromorphone ER, Sodium Benzoate/Sodium Phenylacetate, Oxybutynin ER, Prescription Prenatal Vitamins, Chlorzoxazone (Lorzone AG), Tramadol ER (ConZip AG), Nitrofurantoin and Osmodex ANDAs. The company was founded in 1986 and is headquartered in Bridgewater, NJ.